Patents by Inventor Ingrid Vivika Petterson

Ingrid Vivika Petterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Insulin formulations
    Patent number: 9481721
    Abstract: A stable pharmaceutical formulation containing an insulin derivative can conveniently be prepared by adding glycerol, phenol, m-cresol and zinc ions to it.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: November 1, 2016
    Assignee: Novo Nordisk A/S
    Inventors: Helle Naver, Morten Schlein, Dorte Bjerre Steensgaard, Ingrid Vivika Petterson
  • INSULIN FORMULATIONS
    Publication number: 20150126442
    Abstract: A stable pharmaceutical formulation containing an insulin derivative can conveniently be prepared by adding glycerol, phenol, m-cresol and zinc ions to it.
    Type: Application
    Filed: April 5, 2013
    Publication date: May 7, 2015
    Applicant: NOVO NORDISK A/S
    Inventors: Helle Naver, Morten Schlein, Dorte Bjerre Steensgaard, Ingrid Vivika Petterson
  • Peptides for use in treating obesity
    Patent number: 7541430
    Abstract: Novel cyclic and linear peptides of the formula R1—X—X1—X2—X3—X4—X5—X6—X7—X8—X9—X10—X11—R2 are useful in the treatment of obesity are provided.
    Type: Grant
    Filed: November 7, 2005
    Date of Patent: June 2, 2009
    Assignee: Novo Nordisk A/S
    Inventors: Ulrich Sensfuss, Kilian Waldemar Conde Frieboes, Leif Christensen, Ingrid Vivika Petterson, Thomas Kruse Hansen, Michael Ankersen, Kjeld Madsen
  • Peptides for Use In Treating Obesity
    Publication number: 20090088388
    Abstract: Novel cyclic and linear peptides of the formula R1—X—X1—X2—X3—X4—X5—X6—X7—X8—X9—X10—X11—R2 are useful in the treatment of obesity are provided.
    Type: Application
    Filed: July 8, 2008
    Publication date: April 2, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Ulrich Sensfuss, Kilian Waldemar Conde Frieboes, Leif Christensen, Ingrid Vivika Petterson, Thomas Kruse Hansen, Michael Ankersen, Kjeld Madsen
  • Non-peptide GLP-1 agonists
    Patent number: 6927214
    Abstract: Novel non-peptide GLP-1 agonists, pharmaceutical compositions comprising them, use of the non-peptide GLP-1 agonists for the preparation of pharmaceutical compositions and methods for the treatment and/or prevention of disorders and diseases wherein an activation of the human GLP-1 receptor is beneficial, especially metabolic disorders such as IGT, Type 1 diabetes, Type 2 diabetes and obesity.
    Type: Grant
    Filed: January 14, 2000
    Date of Patent: August 9, 2005
    Assignee: Novo Nordisk A/S
    Inventors: Min Teng, Larry Kenneth Truesdale, Dilip Bhumralkar, Dan Kiel, Michael D. Johnson, Christine Thomas, Anker Steen Jorgensen, Peter Madsen, Preben Houlberg Olesen, Liselotte Bjerre Knudsen, Ingrid Vivika Petterson, Johannes Cornelis de Jong, Carsten Behrens, Janos Tibor Kodra, Jesper Lau